Virbac operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Virbac with three other
companies in this sector in France:
sales of 350.40 million Euro [US$378.81 million]
(775.80 million Euro [US$838.70 million]
(614.49 million Euro [US$664.31 million]
Virbac reported sales of 871.83 million Euro (US$942.52 million)
December of 2016.
increase of 2.3%
versus 2015, when the company's sales were 852.62 million Euro.
Sales at Virbac have increased during each of the previous five years
(and since 2011, sales have increased a total of 40%).